Others

Alembic Pharmaceuticals Ltd. - Announcement under Regulation 30 (LODR)-Press Release / Media Release

| Updated on March 27, 2019 Published on March 27, 2019

With reference to the captioned subject, this is to inform the exchange that the Company has received US Food & Drug Administration (USFDA) Approval for Tadalafil Tablets USP, 2.5 mg, 5 mg, 10 mg and 20 mg.

Please find enclosed herewith our press release.

We request you to kindly take the same on record.

Pdf Link: Alembic Pharmaceuticals Ltd. - Announcement under Regulation 30 (LODR)-Press Release / Media Release

Source : BSE - www.bseindia.com

Published on March 27, 2019
This article is closed for comments.
Please Email the Editor